Continuation, reduction, or withdrawal of tofacitinib in patients with rheumatoid arthritis achieving sustained disease control: a multicenter, open-label, randomized controlled trial
暂无分享,去创建一个
Chengde Yang | Dongbao Zhao | Lindi Jiang | Yulong Xue | Qiong-yi Hu | Jialin Teng | Hong-lei Liu | Xiaobing Cheng | Junna Ye | Yutong Su | Hui Shi | Fang Du | Lili Ma | S. Dai | Mengyan Wang | Yi-Li Tao | L. Lu | Honglei Liu